Rani Therapeutics Holdings, Inc. (RANI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Rani Therapeutics Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.01x | -1.30x | -2.49x | -4.59x | -38.34x | -12.34x |
| P/B Ratio | 2.70x | 19.58x | 6.58x | 3.81x | 6.74x | -1.82x |
| P/S Ratio | 54.68x | 37.95x | 0.00x | 0.00x | 117.55x | 446.16x |
| Profitability | ||||||
| Gross Margin | 44.9% | 100.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Operating Margin | -2346.0% | -5186.2% | 0.0% | 0.0% | -1899.1% | -3581.0% |
| Net Margin | -1817.1% | -2920.0% | 0.0% | 0.0% | -306.6% | -3615.4% |
| EBITDA Margin | -2290.9% | -4914.7% | 0.0% | 0.0% | -1917.0% | -3453.5% |
| Liquidity | ||||||
| Current Ratio | 4.21x | 1.50x | 6.36x | 20.96x | 45.30x | 14.12x |
| Quick Ratio | 4.21x | 1.50x | 6.36x | 20.96x | 45.30x | 14.12x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 14.91x | 2.34x | 0.82x | 0.00x | -0.03x |
YoY = year-over-year change. Source: FMP..